ID   LEG1_HUMAN              Reviewed;         135 AA.
AC   P09382; B2R5E8; Q9UDK5;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 247.
DE   RecName: Full=Galectin-1;
DE            Short=Gal-1;
DE   AltName: Full=14 kDa laminin-binding protein;
DE            Short=HLBP14;
DE   AltName: Full=14 kDa lectin;
DE   AltName: Full=Beta-galactoside-binding lectin L-14-I;
DE   AltName: Full=Galaptin;
DE   AltName: Full=HBL;
DE   AltName: Full=HPL;
DE   AltName: Full=Lactose-binding lectin 1;
DE   AltName: Full=Lectin galactoside-binding soluble 1;
DE   AltName: Full=Putative MAPK-activating protein PM12;
DE   AltName: Full=S-Lac lectin 1;
GN   Name=LGALS1 {ECO:0000312|HGNC:HGNC:6561};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=2719964; DOI=10.1016/0167-4781(89)90173-5;
RA   Hirabayashi J., Ayaki K., Soma G., Kasai K.;
RT   "Cloning and nucleotide sequence of a full-length cDNA for human 14 kDa
RT   beta-galactoside-binding lectin.";
RL   Biochim. Biophys. Acta 1008:85-91(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta, and Promyelocytic leukemia;
RX   PubMed=2910856; DOI=10.1016/s0021-9258(19)85087-1;
RA   Couraud P.-O., Casentini-Borocz D., Bringman T.S., Griffith J.,
RA   McGrogan M., Nedwin G.E.;
RT   "Molecular cloning, characterization, and expression of a human 14-kDa
RT   lectin.";
RL   J. Biol. Chem. 264:1310-1316(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hepatoma;
RX   PubMed=2719646; DOI=10.1042/bj2590291;
RA   Abbott W.M., Feizi T.;
RT   "Evidence that the 14 kDa soluble beta-galactoside-binding lectin in man is
RT   encoded by a single gene.";
RL   Biochem. J. 259:291-294(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=18824694; DOI=10.1073/pnas.0807606105;
RA   Than N.G., Romero R., Erez O., Weckle A., Tarca A.L., Hotra J., Abbas A.,
RA   Han Y.M., Kim S.S., Kusanovic J.P., Gotsch F., Hou Z., Santolaya-Forgas J.,
RA   Benirschke K., Papp Z., Grossman L.I., Goodman M., Wildman D.E.;
RT   "Emergence of hormonal and redox regulation of galectin-1 in placental
RT   mammals: implication in maternal-fetal immune tolerance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:15819-15824(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lymphocyte;
RX   PubMed=1988031; DOI=10.1021/bi00215a013;
RA   Gitt M.A., Barondes S.H.;
RT   "Genomic sequence and organization of two members of a human lectin gene
RT   family.";
RL   Biochemistry 30:82-89(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung fibroblast;
RX   PubMed=12761501; DOI=10.1038/sj.onc.1206406;
RA   Matsuda A., Suzuki Y., Honda G., Muramatsu S., Matsuzaki O., Nagano Y.,
RA   Doi T., Shimotohno K., Harada T., Nishida E., Hayashi H., Sugano S.;
RT   "Large-scale identification and characterization of human genes that
RT   activate NF-kappaB and MAPK signaling pathways.";
RL   Oncogene 22:3307-3318(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-135.
RC   TISSUE=Placenta;
RX   PubMed=3065332; DOI=10.1093/oxfordjournals.jbchem.a122401;
RA   Hirabayashi J., Kasai K.;
RT   "Complete amino acid sequence of a beta-galactoside-binding lectin from
RT   human placenta.";
RL   J. Biochem. 104:1-4(1988).
RN   [14]
RP   PROTEIN SEQUENCE OF 2-135.
RC   TISSUE=Brain;
RA   Bladier D., le Caer J.-P., Joubert R., Caron M., Rossier J.;
RT   "Beta-galactosidase soluble lectin from human brain: complete amino acid
RT   sequence.";
RL   Neurochem. Int. 18:275-281(1991).
RN   [15]
RP   PROTEIN SEQUENCE OF 2-19.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [16]
RP   PROTEIN SEQUENCE OF 38-49; 101-108 AND 113-128, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [17]
RP   PROTEIN SEQUENCE OF 70-87 AND 122-133.
RC   TISSUE=Placenta;
RX   PubMed=3611046; DOI=10.1093/oxfordjournals.jbchem.a121968;
RA   Hirabayashi J., Kawasaki H., Suzuki K., Kasai K.;
RT   "Further characterization and structural studies on human placenta
RT   lectin.";
RL   J. Biochem. 101:987-995(1987).
RN   [18]
RP   PROTEIN SEQUENCE OF 20-29; 50-74 AND 132-135, AND INTERACTION WITH LAMININ.
RC   TISSUE=Melanoma;
RX   PubMed=1386213; DOI=10.1016/0003-9861(92)90650-l;
RA   Castronovo V., Luyten F., van den Brule F., Sobel M.E.;
RT   "Identification of a 14-kDa laminin binding protein (HLBP14) in human
RT   melanoma cells that is identical to the 14-kDa galactoside binding
RT   lectin.";
RL   Arch. Biochem. Biophys. 297:132-138(1992).
RN   [19]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Spleen;
RX   PubMed=2383549; DOI=10.1021/bi00474a014;
RA   Sharma A., Chemelli R., Allen H.J.;
RT   "Human splenic galaptin: physicochemical characterization.";
RL   Biochemistry 29:5309-5314(1990).
RN   [20]
RP   CHARACTERIZATION.
RX   PubMed=7501023; DOI=10.1038/378736a0;
RA   Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G.;
RT   "Apoptosis of T cells mediated by galectin-1.";
RL   Nature 378:736-739(1995).
RN   [21]
RP   CHARACTERIZATION.
RC   TISSUE=Placenta;
RX   PubMed=10369126; DOI=10.1016/s0165-2478(99)00012-7;
RA   Walzel H., Schulz U., Neels P., Brock J.;
RT   "Galectin-1, a natural ligand for the receptor-type protein tyrosine
RT   phosphatase CD45.";
RL   Immunol. Lett. 67:193-202(1999).
RN   [22]
RP   CHARACTERIZATION.
RX   PubMed=10764829; DOI=10.1093/glycob/10.4.413;
RA   Fouillit M., Joubert-Caron R., Poirier F., Bourin P., Monostori E.,
RA   Levi-Strauss M., Raphael M., Bladier D., Caron M.;
RT   "Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B
RT   cells.";
RL   Glycobiology 10:413-419(2000).
RN   [23]
RP   INTERACTION WITH LGALS3BP.
RX   PubMed=11146440;
RX   DOI=10.1002/1097-0215(200002)9999:9999<::aid-ijc1022>3.3.co;2-q;
RA   Tinari N., Kuwabara I., Huflejt M.E., Shen P.F., Iacobelli S., Liu F.-T.;
RT   "Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-
RT   1-induced cell aggregation.";
RL   Int. J. Cancer 91:167-172(2001).
RN   [24]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=14617626; DOI=10.1074/jbc.m311183200;
RA   He J., Baum L.G.;
RT   "Presentation of galectin-1 by extracellular matrix triggers T cell
RT   death.";
RL   J. Biol. Chem. 279:4705-4712(2004).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RA   Ahamed M.E., Ahmed M.E., Eltoum A.M., Altahir G.O., Ahmed K.M., Harbi S.O.,
RA   Stansalas J., Mohamed A.O.;
RT   "Abnormal proteins in primary breast cancer tissues from 25 Sudanese
RT   patients.";
RL   Eur. J. Inflamm. 6:115-121(2008).
RN   [26]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19497882; DOI=10.1073/pnas.0903568106;
RA   Than N.G., Romero R., Goodman M., Weckle A., Xing J., Dong Z., Xu Y.,
RA   Tarquini F., Szilagyi A., Gal P., Hou Z., Tarca A.L., Kim C.J., Kim J.S.,
RA   Haidarian S., Uddin M., Bohn H., Benirschke K., Santolaya-Forgas J.,
RA   Grossman L.I., Erez O., Hassan S.S., Zavodszky P., Papp Z., Wildman D.E.;
RT   "A primate subfamily of galectins expressed at the maternal-fetal interface
RT   that promote immune cell death.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:9731-9736(2009).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-29, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [32]
RP   INTERACTION WITH SUSD2.
RX   PubMed=23131994; DOI=10.1158/1541-7786.mcr-12-0501-t;
RA   Watson A.P., Evans R.L., Egland K.A.;
RT   "Multiple functions of sushi domain containing 2 (SUSD2) in breast
RT   tumorigenesis.";
RL   Mol. Cancer Res. 11:74-85(2013).
RN   [33]
RP   INTERACTION WITH CD6 AND ALCAM, AND FUNCTION.
RX   PubMed=24945728; DOI=10.1016/j.febslet.2014.05.064;
RA   Escoda-Ferran C., Carrasco E., Caballero-Banos M., Miro-Julia C.,
RA   Martinez-Florensa M., Consuegra-Fernandez M., Martinez V.G., Liu F.T.,
RA   Lozano F.;
RT   "Modulation of CD6 function through interaction with galectin-1 and -3.";
RL   FEBS Lett. 588:2805-2813(2014).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   PHOSPHORYLATION AT SER-30.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [37]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TMED10.
RX   PubMed=32272059; DOI=10.1016/j.cell.2020.03.031;
RA   Zhang M., Liu L., Lin X., Wang Y., Li Y., Guo Q., Li S., Sun Y., Tao X.,
RA   Zhang D., Lv X., Zheng L., Ge L.;
RT   "A Translocation Pathway for Vesicle-Mediated Unconventional Protein
RT   Secretion.";
RL   Cell 181:637-652(2020).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH CARBOHYDRATE, AND
RP   SUBUNIT.
RX   PubMed=15476813; DOI=10.1016/j.jmb.2004.08.078;
RA   Lopez-Lucendo M.F., Solis D., Andre S., Hirabayashi J., Kasai K.,
RA   Kaltner H., Gabius H.-J., Romero A.;
RT   "Growth-regulatory human galectin-1: crystallographic characterisation of
RT   the structural changes induced by single-site mutations and their impact on
RT   the thermodynamics of ligand binding.";
RL   J. Mol. Biol. 343:957-970(2004).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 2-135 IN COMPLEX WITH LACTOSE,
RP   INTERACTION WITH CD2; CD3; CD7; CD43 AND CD45, SUBUNIT, AND FUNCTION.
RX   PubMed=18796645; DOI=10.1093/glycob/cwn089;
RA   Nishi N., Abe A., Iwaki J., Yoshida H., Itoh A., Shoji H., Kamitori S.,
RA   Hirabayashi J., Nakamura T.;
RT   "Functional and structural bases of a cysteine-less mutant as a long-
RT   lasting substitute for galectin-1.";
RL   Glycobiology 18:1065-1073(2008).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS).
RX   PubMed=19128029; DOI=10.1021/bi801855g;
RA   Di Lella S., Ma L., Ricci J.C., Rabinovich G.A., Asher S.A.,
RA   Alvarez R.M.S.;
RT   "Critical role of the solvent environment in galectin-1 binding to the
RT   disaccharide lactose.";
RL   Biochemistry 48:786-791(2009).
CC   -!- FUNCTION: Lectin that binds beta-galactoside and a wide array of
CC       complex carbohydrates. Plays a role in regulating apoptosis, cell
CC       proliferation and cell differentiation. Inhibits CD45 protein
CC       phosphatase activity and therefore the dephosphorylation of Lyn kinase.
CC       Strong inducer of T-cell apoptosis. {ECO:0000269|PubMed:14617626,
CC       ECO:0000269|PubMed:18796645, ECO:0000269|PubMed:19497882,
CC       ECO:0000269|PubMed:24945728}.
CC   -!- SUBUNIT: Homodimer. Binds LGALS3BP. Interacts with CD2, CD3, CD4, CD6,
CC       CD7, CD43, ALCAM and CD45. Interacts with laminin (via poly-N-
CC       acetyllactosamine). Interacts with SUSD2. Interacts with cargo receptor
CC       TMED10; the interaction mediates the translocation from the cytoplasm
CC       into the ERGIC (endoplasmic reticulum-Golgi intermediate compartment)
CC       and thereby secretion (PubMed:32272059). {ECO:0000269|PubMed:11146440,
CC       ECO:0000269|PubMed:1386213, ECO:0000269|PubMed:15476813,
CC       ECO:0000269|PubMed:18796645, ECO:0000269|PubMed:23131994,
CC       ECO:0000269|PubMed:24945728, ECO:0000269|PubMed:32272059}.
CC   -!- INTERACTION:
CC       P09382; Q13740: ALCAM; NbExp=3; IntAct=EBI-1048875, EBI-1188108;
CC       P09382; P02649: APOE; NbExp=3; IntAct=EBI-1048875, EBI-1222467;
CC       P09382; P27797: CALR; NbExp=3; IntAct=EBI-1048875, EBI-1049597;
CC       P09382; P30203: CD6; NbExp=2; IntAct=EBI-1048875, EBI-2873748;
CC       P09382; P36957: DLST; NbExp=3; IntAct=EBI-1048875, EBI-351007;
CC       P09382; P35968: KDR; NbExp=3; IntAct=EBI-1048875, EBI-1005487;
CC       P09382; Q8TDX7: NEK7; NbExp=3; IntAct=EBI-1048875, EBI-1055945;
CC       P09382; P16284: PECAM1; NbExp=4; IntAct=EBI-1048875, EBI-716404;
CC       P09382; P08575: PTPRC; NbExp=2; IntAct=EBI-1048875, EBI-1341;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:14617626}. Cytoplasm
CC       {ECO:0000269|PubMed:32272059}. Secreted {ECO:0000269|PubMed:32272059}.
CC       Note=Can be secreted; the secretion is dependent on protein unfolding
CC       and facilitated by the cargo receptor TMED10; it results in protein
CC       translocation from the cytoplasm into the ERGIC (endoplasmic reticulum-
CC       Golgi intermediate compartment) followed by vesicle entry and
CC       secretion. {ECO:0000269|PubMed:32272059}.
CC   -!- TISSUE SPECIFICITY: Expressed in placenta, maternal decidua and fetal
CC       membranes. Within placenta, expressed in trophoblasts, stromal cells,
CC       villous endothelium, syncytiotrophoblast apical membrane and villous
CC       stroma. Within fetal membranes, expressed in amnion, chorioamniotic
CC       mesenchyma and chorion (at protein level). Expressed in cardiac,
CC       smooth, and skeletal muscle, neurons, thymus, kidney and hematopoietic
CC       cells. {ECO:0000269|PubMed:18824694, ECO:0000269|PubMed:19497882}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Galectin-1;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Stlect_00116";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14829; CAA32938.1; -; mRNA.
DR   EMBL; J04456; AAA36170.1; -; mRNA.
DR   EMBL; X15256; CAA33328.1; -; mRNA.
DR   EMBL; EU363770; ACA58297.1; -; mRNA.
DR   EMBL; M57678; AAB00777.1; -; Genomic_DNA.
DR   EMBL; AB097036; BAC77389.1; -; mRNA.
DR   EMBL; CR456511; CAG30397.1; -; mRNA.
DR   EMBL; AK312161; BAG35095.1; -; mRNA.
DR   EMBL; BT006775; AAP35421.1; -; mRNA.
DR   EMBL; Z83844; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60178.1; -; Genomic_DNA.
DR   EMBL; BC001693; AAH01693.1; -; mRNA.
DR   EMBL; BC020675; AAH20675.1; -; mRNA.
DR   CCDS; CCDS13954.1; -.
DR   PIR; A37134; LNHUGB.
DR   RefSeq; NP_002296.1; NM_002305.3.
DR   PDB; 1GZW; X-ray; 1.70 A; A/B=2-135.
DR   PDB; 1W6M; X-ray; 2.30 A; A/B=2-135.
DR   PDB; 1W6N; X-ray; 1.65 A; A/B=2-135.
DR   PDB; 1W6O; X-ray; 1.90 A; A/B=2-135.
DR   PDB; 1W6P; X-ray; 1.80 A; A/B=2-135.
DR   PDB; 1W6Q; X-ray; 2.10 A; A/B=2-135.
DR   PDB; 2KM2; NMR; -; A/B=2-135.
DR   PDB; 2ZKN; X-ray; 1.86 A; A/B=2-135.
DR   PDB; 3OY8; X-ray; 2.19 A; A/B=2-135.
DR   PDB; 3OYW; X-ray; 2.50 A; A/B=2-135.
DR   PDB; 3T2T; X-ray; 1.90 A; A/B=1-135.
DR   PDB; 3W58; X-ray; 1.58 A; A/B/C/D=2-135.
DR   PDB; 3W59; X-ray; 2.10 A; A/B/C/D=2-135.
DR   PDB; 4Q1P; X-ray; 1.46 A; A/B=1-135.
DR   PDB; 4Q1R; X-ray; 1.47 A; A/B=1-135.
DR   PDB; 4Q26; X-ray; 1.40 A; A/B/G/H=1-135.
DR   PDB; 4Q27; X-ray; 1.20 A; A/B=1-135.
DR   PDB; 4Q2F; X-ray; 1.40 A; A/B=1-135.
DR   PDB; 4XBL; X-ray; 1.93 A; A/B=1-135.
DR   PDB; 4Y1U; X-ray; 1.76 A; A/B=3-135.
DR   PDB; 4Y1V; X-ray; 2.32 A; A/B=3-135.
DR   PDB; 4Y1X; X-ray; 2.45 A; A/B=3-135.
DR   PDB; 4Y1Y; X-ray; 1.86 A; A/B=4-135.
DR   PDB; 4Y1Z; X-ray; 2.23 A; A/B=3-135.
DR   PDB; 4Y20; X-ray; 2.20 A; A/B=3-135.
DR   PDB; 4Y22; X-ray; 2.50 A; A/B=3-135.
DR   PDB; 4Y24; X-ray; 2.32 A; A/B=3-135.
DR   PDB; 5MWT; X-ray; 1.71 A; A/B=3-135.
DR   PDB; 5MWX; X-ray; 1.29 A; A/B=3-135.
DR   PDB; 6B94; X-ray; 1.80 A; A/B=2-135.
DR   PDB; 6F83; X-ray; 2.20 A; A/B=2-135.
DR   PDB; 6M5Y; X-ray; 1.38 A; A=1-135.
DR   PDB; 7LTA; X-ray; 1.53 A; A/B=3-135.
DR   PDB; 7NML; X-ray; 1.43 A; A/B=3-135.
DR   PDBsum; 1GZW; -.
DR   PDBsum; 1W6M; -.
DR   PDBsum; 1W6N; -.
DR   PDBsum; 1W6O; -.
DR   PDBsum; 1W6P; -.
DR   PDBsum; 1W6Q; -.
DR   PDBsum; 2KM2; -.
DR   PDBsum; 2ZKN; -.
DR   PDBsum; 3OY8; -.
DR   PDBsum; 3OYW; -.
DR   PDBsum; 3T2T; -.
DR   PDBsum; 3W58; -.
DR   PDBsum; 3W59; -.
DR   PDBsum; 4Q1P; -.
DR   PDBsum; 4Q1R; -.
DR   PDBsum; 4Q26; -.
DR   PDBsum; 4Q27; -.
DR   PDBsum; 4Q2F; -.
DR   PDBsum; 4XBL; -.
DR   PDBsum; 4Y1U; -.
DR   PDBsum; 4Y1V; -.
DR   PDBsum; 4Y1X; -.
DR   PDBsum; 4Y1Y; -.
DR   PDBsum; 4Y1Z; -.
DR   PDBsum; 4Y20; -.
DR   PDBsum; 4Y22; -.
DR   PDBsum; 4Y24; -.
DR   PDBsum; 5MWT; -.
DR   PDBsum; 5MWX; -.
DR   PDBsum; 6B94; -.
DR   PDBsum; 6F83; -.
DR   PDBsum; 6M5Y; -.
DR   PDBsum; 7LTA; -.
DR   PDBsum; 7NML; -.
DR   AlphaFoldDB; P09382; -.
DR   BMRB; P09382; -.
DR   SMR; P09382; -.
DR   BioGRID; 110147; 285.
DR   ComplexPortal; CPX-92; Galectin-1 complex.
DR   CORUM; P09382; -.
DR   DIP; DIP-46153N; -.
DR   IntAct; P09382; 63.
DR   MINT; P09382; -.
DR   STRING; 9606.ENSP00000215909; -.
DR   BindingDB; P09382; -.
DR   ChEMBL; CHEMBL4915; -.
DR   DrugBank; DB04447; 1,4-Dithiothreitol.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB03345; Mercaptoethanol.
DR   DrugBank; DB04396; Thiodigalactoside.
DR   MoonDB; P09382; Curated.
DR   UniLectin; P09382; -.
DR   GlyGen; P09382; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P09382; -.
DR   MetOSite; P09382; -.
DR   PhosphoSitePlus; P09382; -.
DR   SwissPalm; P09382; -.
DR   BioMuta; LGALS1; -.
DR   DMDM; 126155; -.
DR   DOSAC-COBS-2DPAGE; P09382; -.
DR   REPRODUCTION-2DPAGE; IPI00219219; -.
DR   REPRODUCTION-2DPAGE; P09382; -.
DR   SWISS-2DPAGE; P09382; -.
DR   UCD-2DPAGE; P09382; -.
DR   CPTAC; CPTAC-1436; -.
DR   CPTAC; CPTAC-1437; -.
DR   CPTAC; CPTAC-1438; -.
DR   CPTAC; CPTAC-1439; -.
DR   CPTAC; CPTAC-1440; -.
DR   CPTAC; CPTAC-706; -.
DR   EPD; P09382; -.
DR   jPOST; P09382; -.
DR   MassIVE; P09382; -.
DR   MaxQB; P09382; -.
DR   PaxDb; P09382; -.
DR   PeptideAtlas; P09382; -.
DR   PRIDE; P09382; -.
DR   ProteomicsDB; 52215; -.
DR   TopDownProteomics; P09382; -.
DR   ABCD; P09382; 3 sequenced antibodies.
DR   Antibodypedia; 269; 1008 antibodies from 46 providers.
DR   CPTC; P09382; 1 antibody.
DR   DNASU; 3956; -.
DR   Ensembl; ENST00000215909.10; ENSP00000215909.5; ENSG00000100097.12.
DR   GeneID; 3956; -.
DR   KEGG; hsa:3956; -.
DR   MANE-Select; ENST00000215909.10; ENSP00000215909.5; NM_002305.4; NP_002296.1.
DR   UCSC; uc003atn.4; human.
DR   CTD; 3956; -.
DR   DisGeNET; 3956; -.
DR   GeneCards; LGALS1; -.
DR   HGNC; HGNC:6561; LGALS1.
DR   HPA; ENSG00000100097; Low tissue specificity.
DR   MIM; 150570; gene.
DR   neXtProt; NX_P09382; -.
DR   OpenTargets; ENSG00000100097; -.
DR   PharmGKB; PA30337; -.
DR   VEuPathDB; HostDB:ENSG00000100097; -.
DR   eggNOG; KOG3587; Eukaryota.
DR   GeneTree; ENSGT00940000155534; -.
DR   HOGENOM; CLU_037794_5_0_1; -.
DR   InParanoid; P09382; -.
DR   OMA; KIKCMAF; -.
DR   OrthoDB; 1429018at2759; -.
DR   PhylomeDB; P09382; -.
DR   TreeFam; TF315551; -.
DR   PathwayCommons; P09382; -.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SignaLink; P09382; -.
DR   SIGNOR; P09382; -.
DR   BioGRID-ORCS; 3956; 13 hits in 1084 CRISPR screens.
DR   ChiTaRS; LGALS1; human.
DR   EvolutionaryTrace; P09382; -.
DR   GeneWiki; Galectin-1; -.
DR   GeneWiki; LGALS1; -.
DR   GenomeRNAi; 3956; -.
DR   Pharos; P09382; Tchem.
DR   PRO; PR:P09382; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P09382; protein.
DR   Bgee; ENSG00000100097; Expressed in stromal cell of endometrium and 205 other tissues.
DR   ExpressionAtlas; P09382; baseline and differential.
DR   Genevisible; P09382; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; HDA:BHF-UCL.
DR   GO; GO:1990724; C:galectin complex; IPI:ComplexPortal.
DR   GO; GO:0030246; F:carbohydrate binding; IBA:GO_Central.
DR   GO; GO:0043236; F:laminin binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0098609; P:cell-cell adhesion; IDA:ComplexPortal.
DR   GO; GO:0045445; P:myoblast differentiation; IEA:Ensembl.
DR   GO; GO:0002317; P:plasma cell differentiation; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:ComplexPortal.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; HMP:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IDA:ComplexPortal.
DR   GO; GO:0046598; P:positive regulation of viral entry into host cell; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0031295; P:T cell costimulation; IEA:Ensembl.
DR   CDD; cd00070; GLECT; 1.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR044156; Galectin-like.
DR   InterPro; IPR001079; Galectin_CRD.
DR   PANTHER; PTHR11346; PTHR11346; 1.
DR   Pfam; PF00337; Gal-bind_lectin; 1.
DR   SMART; SM00908; Gal-bind_lectin; 1.
DR   SMART; SM00276; GLECT; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS51304; GALECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Apoptosis; Cytoplasm; Direct protein sequencing;
KW   Extracellular matrix; Lectin; Phosphoprotein; Reference proteome; Secreted.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801,
FT                   ECO:0000269|PubMed:3065332, ECO:0000269|Ref.14,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378,
FT                   ECO:0007744|PubMed:25944712"
FT   CHAIN           2..135
FT                   /note="Galectin-1"
FT                   /id="PRO_0000076917"
FT   DOMAIN          4..135
FT                   /note="Galectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00639"
FT   BINDING         45..49
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT   BINDING         53
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT   BINDING         62
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT   BINDING         69..72
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P16045"
FT   MOD_RES         29
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         30
FT                   /note="Phosphoserine; by FAM20C"
FT                   /evidence="ECO:0000269|PubMed:26091039"
FT   MOD_RES         108
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P16045"
FT   MOD_RES         108
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P16045"
FT   MOD_RES         128
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P16045"
FT   STRAND          3..12
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          18..24
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          30..38
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          41..52
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          55..65
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          73..76
FT                   /evidence="ECO:0007829|PDB:4Y1U"
FT   STRAND          84..92
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          94..100
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          106..110
FT                   /evidence="ECO:0007829|PDB:4Q27"
FT   STRAND          116..133
FT                   /evidence="ECO:0007829|PDB:4Q27"
SQ   SEQUENCE   135 AA;  14716 MW;  2FBB8D7A1FC0F1F9 CRC64;
     MACGLVASNL NLKPGECLRV RGEVAPDAKS FVLNLGKDSN NLCLHFNPRF NAHGDANTIV
     CNSKDGGAWG TEQREAVFPF QPGSVAEVCI TFDQANLTVK LPDGYEFKFP NRLNLEAINY
     MAADGDFKIK CVAFD
//
